In recent years, many studies have focused on the role of systemic inflammatory markers and immune status in asthma, among which the C-reactive protein-albumin-lymphocyte (CALLY) index, as a comprehensive indicator reflecting the body's inflammation and immune status, has received increasing attention for its association with asthma. The gene discussed is ALB; the disease is asthma.